Virosome-like vesicles comprising gp41-derived antigens
US9216156B2 · kind B2 · utility
27Cited by
2References
30Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Mar 2, 2007 |
| Grant date | Dec 22, 2015 |
| Priority date | — |
| Expiry date | Dec 10, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2740/16134
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a virosome-like vesicle comprising at least a gp41-derived antigen or an analogue thereof, said gp41-derived antigen being located to the external surface of and/or encapsulated inside said vesicle and being in a convenient configuration for conferring said virosome-like vesicle with an ability to induce an immune response against a gp41 protein or a human immunodeficiency virus (HIV).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.